Technical Analysis for ATOS - Atossa Genetics Inc.

Grade Last Price % Change Price Change
C 2.72 -6.53% -0.19
ATOS closed down 6.53 percent on Friday, February 26, 2021, on 44 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical ATOS trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish -6.53%
New Uptrend Bullish -6.53%
Pocket Pivot Bullish Swing Setup -6.53%
Wide Bands Range Expansion -6.53%
Oversold Stochastic Weakness -6.53%
Stochastic Reached Oversold Weakness -2.16%
Wide Bands Range Expansion -2.16%
Oversold Stochastic Weakness -2.16%
New Downtrend Bearish 6.67%
Older End-of-Day Signals for ATOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low 1 day ago
Down 10% 1 day ago
Down 5% 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Atossa Genetics Inc. Description

Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65; and the ArgusCYTE Breast Health Test that offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company also intends to offers FullCYTE Breast Health Test, which is in development to assess the individual breast ducts for pre-cancerous changes in women; and NextCYTE Breast Cancer Test that is in the prevalidation phase to profile breast cancer specimens for prediction of treatment outcomes and distant recurrence in women newly diagnosed with breast cancer. Atossa Genetics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Breast Cancer Genetics Cancer Treatment Diagnostic Tests Risk Assessment Assessment Products Breast Surgery Breast Implant Hereditary Cancers

Is ATOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.08
52 Week Low 0.755
Average Volume 26,145,318
200-Day Moving Average 2.45
50-Day Moving Average 2.03
20-Day Moving Average 3.18
10-Day Moving Average 3.05
Average True Range 0.45
ADX 35.16
+DI 30.42
-DI 27.35
Chandelier Exit (Long, 3 ATRs ) 3.54
Chandelier Exit (Short, 3 ATRs ) 3.32
Upper Bollinger Band 4.25
Lower Bollinger Band 2.12
Percent B (%b) 0.28
BandWidth 66.91
MACD Line 0.19
MACD Signal Line 0.34
MACD Histogram -0.153
Fundamentals Value
Market Cap 28.54 Million
Num Shares 10.5 Million
EPS -2.51
Price-to-Earnings (P/E) Ratio -1.08
Price-to-Sales 0.00
Price-to-Book 1.61
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.32
Resistance 3 (R3) 3.31 3.11 3.22
Resistance 2 (R2) 3.11 2.95 3.11 3.19
Resistance 1 (R1) 2.91 2.86 2.81 2.92 3.15
Pivot Point 2.71 2.71 2.66 2.71 2.71
Support 1 (S1) 2.51 2.55 2.41 2.52 2.29
Support 2 (S2) 2.31 2.46 2.31 2.25
Support 3 (S3) 2.11 2.31 2.22
Support 4 (S4) 2.12